Inhibition of ADA activity using siADA and small molecule ADA inhibitors greatly enhanced the anticancer effects of low cordycepin concentration (1–20 μM) in uveal melanoma cells, with a significant score in formal synergy testing. The gene discussed is ADA; the disease is uveal melanoma.